קופגוס

מדינה: ישראל

שפה: עברית

מקור: Ministry of Health

מרכיב פעיל:

RIBAVIRIN 200 MG

זמין מ:

ROCHE PHARMACEUTICALS (ISRAEL) LTD

קוד ATC:

J05AB04

טופס פרצבטיות:

TABLETS

מסלול נתינה (של תרופות):

PER OS

תוצרת:

HOFFMANN LA ROCHE, SWITZERLAND

קבוצה תרפויטית:

RIBAVIRIN

סממני תרפויטית:

Copegus in combination with peginterferon alfa 2a or interferon alfa - 2a is indicated in adult patients who are positive for serum HCV-RNA, including patients with compensated cirrhosis . The combination with peginterferon alfa-2a is also indicated in patients co-infected with clinically stable HIV , including patients with compensated cirrhosis . Copegus, in combination with peginterferon alfa-2a, is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated) alone or in combination therapy with ribavirin.

תאריך אישור:

2013-04-01